Efficacy of ex vivo Purging with CD34+ Selection to Maximize the Effects of Autologous Stem Cell Transplantation in Peripheral T-cell Lymphoma Patients

Peripheral T-cell lymphomas (PTCLs) are rare and aggressive tumors with uncertain optimal treatment. This study investigated the clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation (HDT/ASCT) after CD34+ selective purging in PTCL patients. Retrospective analy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cytotherapy (Oxford, England) England), 2023-12, Vol.25 (12), p.1307-1316
Hauptverfasser:	Jeon, Youngwoo, Kim, Tong-Yoon, Min, Gi June, Park, Sung-Soo, Park, Silvia, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Kim, Hee-Je, Lee, Seok, Min, Chang-Ki, Lee, Jong-Wook, Cho, Seok-Goo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens, CD34 autologous stem cell transplantation Cell Adhesion Molecules CliniMACS ex vivo purging Hematopoietic Stem Cell Transplantation Humans Lymphoma, T-Cell, Peripheral - therapy Neoplasm Recurrence, Local Peripheral T-cell lymphoma Recurrence Retrospective Studies Transplantation, Autologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!